Skip to main navigation Skip to search Skip to main content

What psychiatrists should know about genes and Alzheimer's disease

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Alzheimer's disease is a devastating illness, and patients may be exceptionally concerned that they have genes that contribute to this illness, especially if there is a family history of Alzheimer's disease. This article reviews core findings regarding the genes that contribute to the earlyonset (familial) and late-onset forms of Alzheimer's disease and related findings regarding the needs of psychiatrists when discussing the disease with patients. Previously, clinicians believed that patients who tested positive for the APOE gene linked to late-onset Alzheimer's disease would be harmed by this knowledge to a greater extent than those who did not know they had the gene. Thus, clinicians were strongly recommending to patients that they not have this testing. This article includes the practice-changing relevance of a recent study published in the New England Journal of Medicine, which reported that a group of patients tested for the APOE gene who found out that they were positive for this gene were not significantly harmed by having acquired this knowledge.

Original languageEnglish
Pages (from-to)45-50
Number of pages6
JournalPsychiatry (Edgemont)
Volume7
Issue number10
StatePublished - Oct 2010

Keywords

  • Alzheimer's disease
  • Apoe gene
  • Early-onset alzheimer's disease
  • Familial Alzheimer's disease
  • Genetic counseling
  • Genetic testing
  • Late-onset alzheimer's disease

Fingerprint

Dive into the research topics of 'What psychiatrists should know about genes and Alzheimer's disease'. Together they form a unique fingerprint.

Cite this